NEW BLOG
“Biosimilars have been proven as safe and effective as the originator biologic and are offered at a reduced price,” explains Dr. Merritt, “However, demand for the product has been slow to shift from the original biologic, especially when clinicians and patients do not regard the products as clinically equivalent even though they have been proven safe and effective.” Read more.
INDUSTRY NEWS
- How payers can manage gene therapies.
- The importance of receiving primary care.
- Mark Cuban’s Cost Plus Drug Co. vs. big pharma.
- Voluntary recall of Vitrakvi due to microbial contamination.
- Voluntary recall of Ting foot spray from Benzene presence.
- Voluntary recall of Sandimmune lots due to crystallization.
- Voluntary recall of multiple injections from particulate matter.